ICI member Prof. Huib Ovaa has been awarded the Bessel award or the “Friedrich Wilhelm Bessel-Forschungspreis” from the Alexander von Humboldt Foundation.
This award has been granted in recognition of past accomplishments in research and teaching.
Executive Board member Prof. Carl Figdor has been awarded an ERC Advanced Grant of € 2.5 million.
Chemist Mario van der Stelt was appointed Professor of Molecular Physiology at the Leiden Institute of Chemistry with effect from 1 November 2017. On Friday October 19th 2018 he gave his inaugural lecture entitled Body's own marijuana: inspiration for drug research.
The full lecture (in Dutch) can be found here.
Prof. Hidde Ploegh has been appointed professor Chemical Immunology, in particular biochemistry of the immune system, at the LUMC. He will take on the Jon J. van Rood Chair effective as of September 1st.
Improved method for quality control of biopharmaceuticals
ICI Executive Board member Albert Heck (Utrecht University) is to receive two international distinctions this summer for his work in biochemistry and mass spectrometry: the prestigious Sir Hans Krebs Medal and the Thomson Medal and Prize. 'It is a wonderful and special honour, especially since they are two completely different awards.'
On September 17th, the Royal Netherlands Academy of Arts and Sciences (KNAW) will install 21 new members, including ICI executive board member Hermen Overkleeft (Leiden University). Since its inception, the Academy has been a learned society of outstanding Dutch scientists and scholars. Membership is awarded on the basis of scientific and scholarly achievement. Members are appointed for life
What determines cell fate?
ICI researcher Mario van der Stelt (Leiden University) has been awarded a prestigious Vici grant by the Netherlands Organisation for Scientific Research (NWO). He receives 1.5 million Euro to develop his own research project (The body's own marijuana) in the coming 5 years.
Researchers at Utrecht University and Leiden University Medical Center, the Netherlands, have for the first time made a picture of an important on-switch of our immune system. Their novel technical approach already led to the discovery of not one, but two ways in which the immune system can be activated. This kind of new insights are important for designing better therapies against infections or cancer, according to team leaders Piet Gros and Thom Sharp. Their findings are published on February 16, 2018 in the journal Science.